Indication
Ocular rosacea
Ocular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently. Read more about Ocular rosacea
23 drugs 12 manufacturers
Drugs that treat it
Common Ocular rosacea therapies.
LOTEPREDNOL ETABONATE
LOTEPREDNOL ETABONATE
LOTEPREDNOL ETABONATE
LOTEPREDNOL ETABONATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOcular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently.
Pathophysiologically driven by neurovascular dysregulation, immune-mediated inflammation, and meibomian gland dysfunction, the condition impairs tear film stability.
Clinical manifestations typically include blepharitis, conjunctival hyperemia, lid margin telangiectasias, recurrent chalazia or hordeola, foreign-body sensation, and dry eye disease.
If untreated, severe or progressive disease can lead to sight-threatening complications such as chronic keratitis, corneal neovascularization, ulceration, and perforation.
- nih.gov
Ocular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently Pathophysiologically driven by neurovascular dysregulation, immune-mediated inflammation, and meibomian gland dysfunction, the condition impairs tear film stability Clinical manifestations typically include blepharitis, conjunctival hyperemia, lid margin telangiectasias, recurrent ...
- nih.gov
Ocular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently
- nih.gov
Ocular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently
- nih.gov
Pathophysiologically driven by neurovascular dysregulation, immune-mediated inflammation, and meibomian gland dysfunction, the condition impairs tear film stability
- aao.org
Clinical manifestations typically include blepharitis, conjunctival hyperemia, lid margin telangiectasias, recurrent chalazia or hordeola, foreign-body sensation, and dry eye disease
- nih.gov
Clinical manifestations typically include blepharitis, conjunctival hyperemia, lid margin telangiectasias, recurrent chalazia or hordeola, foreign-body sensation, and dry eye disease If untreated, severe or progressive disease can lead to sight-threatening complications such as chronic keratitis, corneal neovascularization, ulceration, and perforation
Personalize your experience
Follow Ocular rosacea and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.